| Ms Maureen Catherine Steele, LCSW-C | |
|
8818 Georgia Ave, 2nd Floor, Silver Spring, MD 20910-2713 | |
| (301) 563-7000 | |
| Not Available |
| Full Name | Ms Maureen Catherine Steele |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 23 Years |
| Location | 8818 Georgia Ave, Silver Spring, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437304326 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 14588 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arundel Lodge, Inc. | 8123197050 | 8 |
News Archive
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
The Australian Vaccination Network is involved in controversy yet again. The Bangalow-based anti-vaccination group has been given a timeline of 28 days to answer to claims that it breached charitable fundraising legislation on several occasions. It was only last month that the Health Care Complaints Commission had accused AVN of spreading misleading information about the dangers of immunization through its website.
Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.
› Verified 8 days ago
| Entity Name | Arundel Lodge, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225213507 PECOS PAC ID: 8123197050 Enrollment ID: O20080519000639 |
News Archive
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
The Australian Vaccination Network is involved in controversy yet again. The Bangalow-based anti-vaccination group has been given a timeline of 28 days to answer to claims that it breached charitable fundraising legislation on several occasions. It was only last month that the Health Care Complaints Commission had accused AVN of spreading misleading information about the dangers of immunization through its website.
Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Maureen Catherine Steele, LCSW-C 1398 Lamberton Dr, Suite 3, Silver Spring, MD 20902-3414 Ph: (301) 754-1102 | Ms Maureen Catherine Steele, LCSW-C 8818 Georgia Ave, 2nd Floor, Silver Spring, MD 20910-2713 Ph: (301) 563-7000 |
News Archive
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has raised $8 million through a note offering to existing shareholders. The new funding will be used to further develop its pipeline of cancer vaccine candidates, including its lead product, IRX-2. IRX Therapeutics has now raised a total of more than $80 million in private financing.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated a Phase 2 clinical trial evaluating SCH 900105 (also referred to as AV-299) for the treatment of non-small cell lung cancer. The initiation of this trial triggers an $8.5 million milestone payment by Merck to AVEO resulting from a 2007 agreement between AVEO and Schering-Plough (now Merck).
The Australian Vaccination Network is involved in controversy yet again. The Bangalow-based anti-vaccination group has been given a timeline of 28 days to answer to claims that it breached charitable fundraising legislation on several occasions. It was only last month that the Health Care Complaints Commission had accused AVN of spreading misleading information about the dangers of immunization through its website.
Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.
› Verified 8 days ago
Mrs. Krystle Linnette Tinsley, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1420 Spring St, Silver Spring, MD 20910 Phone: 240-847-7500 | |
Ms. Mairead Burke, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9507 Dallas Ave, Silver Spring, MD 20901 Phone: 240-203-9303 Fax: 240-244-9980 | |
Ms. Thyra Jackson Benoit, LCSW-C, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1107 Spring St Ste A3, Silver Spring, MD 20910 Phone: 301-460-3735 Fax: 301-460-3735 | |
Ms. Tacie Dejanikus, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1398 Lamberton Dr, Silver Spring, MD 20902 Phone: 301-754-1102 Fax: 301-754-1690 | |
Elizabeth J Hood, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8737 Colesville Rd, Suite 700, Silver Spring, MD 20910 Phone: 301-588-8881 | |
Ms. Cari Brown-duncan, LCSW-C, LICSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8701 Georgia Ave, Suite 611, Silver Spring, MD 20910 Phone: 301-565-0720 Fax: 301-565-0721 | |
Ms. Evelyn Goldstein, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11235 Oak Leaf Dr, Suite #110, Silver Spring, MD 20901 Phone: 301-681-8597 Fax: 301-598-6648 |